Results 1 to 10 of about 8,849 (148)

Metastatic collecting duct carcinoma of the kidney treated with sunitinib [PDF]

open access: yesWorld Journal of Surgical Oncology, 2011
Collecting duct carcinoma (CDC) of the kidney is a rare and aggressive malignant tumor arising from the distal collecting tubules which has been shown to have a poor response to several kinds of systemic therapy.
M'rabti Hind   +5 more
doaj   +5 more sources

Collecting duct carcinoma associated with oncocytoma [PDF]

open access: yesInternational Brazilian Journal of Urology, 2005
Collecting duct carcinoma (CDC) is a rare, highly aggressive malignant neoplasm that arises from the collecting duct epithelium of the kidney. CDC was reported to coexist with renal cell and transitional cell carcinomas.
George M. Yousef   +3 more
doaj   +5 more sources

Efficacy of combination therapy with pembrolizumab and axitinib for metastatic renal collecting duct cell carcinoma: A report on two cases

open access: yesIJU Case Reports, 2022
Introduction Immunotherapy‐based combinations have become the standard first‐line therapy for metastatic renal cell carcinoma. However, combined immunotherapy for renal collecting duct carcinoma had been reported, but its therapeutic efficacy had been ...
Shinji Tamada   +8 more
doaj   +2 more sources

Renal Collecting Duct Carcinoma and Concomitant Bladder Urothelial Carcinoma: A Case Report

open access: yesKaohsiung Journal of Medical Sciences, 2008
The simultaneous occurrence of renal collecting duct (Bellini duct) carcinoma and bladder urothelial carcinoma is very rare. A 68-year-old female patient with bladder urothelial carcinoma first received transurethral resection of the tumor.
Hsi-Lin Hsiao   +7 more
doaj   +3 more sources

A rare case of collecting duct carcinoma with first presentation of respiratory symptoms

open access: yesUrology Case Reports, 2020
We are reporting a rare case of collecting duct carcinoma in a 45years old male who was seeking for medical treatment of his persistent cough, dyspnea and weight loss. Chest x-ray revealed multiple focal opacities. Axial Contrast enhanced CT scan for the
Abdulkarim Hasan   +4 more
doaj   +3 more sources

Bellini Duct Carcinoma: A Rare Entity [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Bellini duct carcinoma of kidney derives from collecting duct and is associated with an aggressive course and extremely poor prognosis. Here, we report an interesting case of Collecting Duct Carcinoma (CDC) with Inferior Vena Cava (IVC) thrombus and ...
Amit Kumar Mishra   +4 more
doaj   +1 more source

Collecting Duct Carcinoma and Endemic Nephropathy – Case Reports and Literature Review

open access: yesActa Clinica Croatica, 2020
Although collecting duct carcinoma is a subtype of renal cell carcinoma, several studies implicate association with urothelial carcinoma. The coexistence of collecting duct carcinoma and another renal neoplasm is rare.
Matej Knežević   +7 more
doaj   +1 more source

Collecting Duct Carcinoma: A Rare Entity

open access: yesQanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya, 2020
Collecting duct carcinoma is a rare and highly aggressive subtype of renal cell carcinoma. The incidence rate is less than 1-2% of all renal tumors and usually, affect middle-aged adult, commonly in men.
Ferdinant Martinus Djawa   +1 more
doaj   +1 more source

Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma

open access: yesCase Reports in Urology, 2021
Collecting duct carcinoma (CDC) is a rare, extremely aggressive form of renal cancer. Recently, immune checkpoint inhibitors (ICI), anti-programmed death-1 (PD-1) antibody, and anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) antibody were ...
Tetsuya Danno   +5 more
doaj   +1 more source

Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Collecting duct carcinoma and sarcomatoid renal cell carcinoma are tumors with poor prognosis. Immune checkpoint inhibitors have been established as the standard treatment for advanced renal cell carcinoma.
Takayoshi Fuu   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy